Improving Diabetes Equity and Advancing Care Study

Description

The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is to determine optimization of intervention components. Participants will be randomly assigned to diabetes self-management training or remote glucose monitoring. After 6 months, participants will be rerandomized to a subsequent study arm (including a CHW support program) depending on a tailoring variable of change in A1c. Researchers will compare the final 6 study arms to see which combination and sequence of enhancements produces the most improvement in A1c.

Conditions

Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Study Overview

Study Details

Study overview

The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is to determine optimization of intervention components. Participants will be randomly assigned to diabetes self-management training or remote glucose monitoring. After 6 months, participants will be rerandomized to a subsequent study arm (including a CHW support program) depending on a tailoring variable of change in A1c. Researchers will compare the final 6 study arms to see which combination and sequence of enhancements produces the most improvement in A1c.

Improving Diabetes Equity and Advancing Care Study

Improving Diabetes Equity and Advancing Care Study

Condition
Diabetes
Intervention / Treatment

-

Contacts and Locations

Chicago

Mount Sinai Hospital, Chicago, Illinois, United States, 60608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A diagnosis of type 1 or type 2 diabetes
  • * 18+ years of age
  • * Able to provide consent
  • * Identify as African American/Black or Latinx
  • * most recent HbA1c \> 7%,
  • * Have a smartphone compatible with the Glooko application
  • * Have completed at least one Center appointment (i.e. current patient)
  • * Completed at least 3 months of their assigned study condition
  • * Already an active user of RGM
  • * Actively working with a CHW
  • * Diagnosis of gestational diabetes (without type 1 or type 2)
  • * Has a Power of Attorney
  • * Be suffering from Stage-V renal disease or undergoing dialysis.
  • * Be suffering from a severe form of cardiovascular disease (NYHA Class III and IV)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Sinai Health System,

Study Record Dates

2025-03-31